When a group like Monness, Crespi and Hardt don't like you what's left..........
An analyst at Monness, Crespi, Hardt downgraded shares of Momenta Pharmaceuticals from Buy to Neutral in an intraday note today. The stock dipped in mid-day trading as the downgrade began hitting wires, however shares seem to be bouncing.
Market Data 
Markets 
AI
